Advertisement

Advertisement

CH:SDZ Stock Latest News

Sandoz price target lowered to CHF 65 from CHF 70 at Deutsche Bank

The FlySandoz price target lowered to CHF 65 from CHF 70 at Deutsche Bank

Sandoz lifts Q1 sales on biosimilars surge and confirms 2026 outlook

PremiumCompany Announcements

Sandoz lifts Q1 sales on biosimilars surge and confirms 2026 outlook

4d ago

Sandoz seals Rwanda supply deal to bolster access to critical medicines in Africa

PremiumCompany Announcements

Sandoz seals Rwanda supply deal to bolster access to critical medicines in Africa

18d ago

Sandoz price target raised to CHF 75 from CHF 66 at JPMorgan

PremiumThe Fly

Sandoz price target raised to CHF 75 from CHF 66 at JPMorgan

19d ago

Sandoz marks 20 years of Omnitrope as biosimilar savings set stage for “golden decade”

PremiumCompany Announcements

Sandoz marks 20 years of Omnitrope as biosimilar savings set stage for “golden decade”

20d ago

Sandoz investors back all AGM proposals, approve CHF 0.80 dividend

PremiumCompany AnnouncementsSandoz investors back all AGM proposals, approve CHF 0.80 dividend

24d ago

Sandoz initiated with a Buy at Goldman Sachs

The Fly

Sandoz initiated with a Buy at Goldman Sachs

1M ago

Sandoz downgraded to Sector Perform from Outperform at RBC Capital

The Fly

Sandoz downgraded to Sector Perform from Outperform at RBC Capital

1M ago

Sandoz announces partnership agreement with Samsung Bioepis

PremiumThe Fly

Sandoz announces partnership agreement with Samsung Bioepis

2M ago

Sandoz deepens Samsung Bioepis alliance to add up to five new biosimilars

PremiumCompany Announcements

Sandoz deepens Samsung Bioepis alliance to add up to five new biosimilars

2M ago

Sandoz Raises CHF 550 Million in Bonds and Extends USD 2 Billion Credit Line

PremiumCompany Announcements

Sandoz Raises CHF 550 Million in Bonds and Extends USD 2 Billion Credit Line

2M ago

Sandoz reshapes biosimilar and generics leadership to seize upcoming patent cliff

PremiumCompany Announcements

Sandoz reshapes biosimilar and generics leadership to seize upcoming patent cliff

2M ago

Sandoz price target raised to CHF 62 from CHF 55 at Berenberg

PremiumThe FlySandoz price target raised to CHF 62 from CHF 55 at Berenberg

2M ago

Sandoz downgraded to Hold from Buy at Deutsche Bank

The Fly

Sandoz downgraded to Hold from Buy at Deutsche Bank

2M ago

Sandoz downgraded to Equal Weight from Overweight at Barclays

The Fly

Sandoz downgraded to Equal Weight from Overweight at Barclays

2M ago

Sandoz lifts profit, dividend and 2026 outlook on biosimilar-driven growth

PremiumCompany Announcements

Sandoz lifts profit, dividend and 2026 outlook on biosimilar-driven growth

2M ago

Sandoz confirms E.C. granted marketing authorization for Ranluspec

PremiumThe Fly

Sandoz confirms E.C. granted marketing authorization for Ranluspec

2M ago

Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push

PremiumCompany Announcements

Sandoz wins EU approval for Ranluspec biosimilar, bolstering ophthalmology push

2M ago

Sandoz receives U.S. FDA approval to expand Enzeevu label

PremiumThe Fly

Sandoz receives U.S. FDA approval to expand Enzeevu label

2M ago

Sandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar

PremiumCompany AnnouncementsSandoz Wins Expanded U.S. FDA Label for Enzeevu Retinal Biosimilar

2M ago

Sandoz upgraded to Buy from Hold at Jefferies

The Fly

Sandoz upgraded to Buy from Hold at Jefferies

3M ago

Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank

The Fly

Sandoz price target raised to CHF 63 from CHF 60 at Deutsche Bank

3M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >